Clinical Trials in Denver

Showing 12041-12060 of 18,161 trials

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

NCT01233375

The purpose of this study is to determine whether CO-1.01 is safe and effective for treating metastatic pancreatic cancer that did not respond to gemcitabine.

Metastatic Pancreatic Adenocarcinoma

Clovis Oncology, Inc.19 participantsStarted Apr 2011

Tucson, Arizona, United States • Denver, Colorado, United States • Boynton Beach, Florida, United States +10 more locations

COMPLETEDPhase 1< 1 mile

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

NCT02614612

To determine if Itacitinib in combination with corticosteroids is safe and tolerable in patients with Grade IIB-IVD acute graft-versus-host disease (GVHD).

Graft-versus-host Disease (GVHD)

Incyte Corporation31 participantsStarted Dec 2015

Duarte, California, United States • La Jolla, California, United States • Los Angeles, California, United States +20 more locations

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Find Trials by Condition in Denver

Inflammation and the Host Response to Injury (Trauma)

A Study of LY2928057 in Hemodialysis Participants

Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE)

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis

HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02

Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors